Annual EBITDA
$2.73B$47.28M+1.76%
Summary
- Current Value
- As of today, DVA annual EBITDA is $2.73B, up +1.76% on
- Historical Performance
- DVA annual EBITDA is up +33.29% over the past 3 years, up +17.78% over the past 5 years
- All-Time High Comparison
- DVA annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- DVA annual EBITDA is +33.29% above its 3-year low of $2.05B reached on an earlier date
- Sector Comparison
- DVA annual EBITDA is higher than 96.14% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $2.73B | +1.8% | +33.3% | +17.8% | +123.0% | |
| Quarterly EBITDA | $651.38M | +6.8% | +34.9% | +8.5% | +120.0% | |
| TTM EBITDA | $2.77B | +4.1% | +36.8% | +19.7% | +126.7% | |
| Price | $198.65 | +38.3% | +122.7% | +56.7% | +371.0% | |
| PE Ratio | 19.07 | +34.1% | +12.7% | +0.2% | -13.0% | |
| Annual Revenue | $13.64B | +6.5% | +17.5% | +18.1% | +111.6% | |
| Annual EPS | $9.51 | -11.3% | +66.7% | +48.9% | +382.8% | |
| $2.01B | +2.9% | +53.2% | +19.4% | +103.5% | ||
| Annual Net Income | $1.05B | -15.8% | +37.2% | +4.9% | +117.6% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $2.73B | at high | |
| 5Y | $2.73B | at high | |
| All | $2.73B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $2.05B | N/A | +33.3% |
| 5Y | $2.05B | +33.3% | |
| All | $21.90M | >+9999.0% |
EBITDA History
FAQ
What is the current annual EBITDA of DVA?
As of today, DVA annual EBITDA is $2.73B
What is 1-year change in DVA annual EBITDA?
DVA annual EBITDA is up +1.76% year-over-year
What is 3-year change in DVA annual EBITDA?
DVA annual EBITDA is up +33.29% over the past 3 years
How far is DVA annual EBITDA from its all-time high?
DVA annual EBITDA is currently at its all-time high
How does DVA annual EBITDA rank versus sector peers?
DVA annual EBITDA is higher than 96.14% of companies in Healthcare sector
When is DVA next annual earnings release?
As of today, the next annual earnings release for DVA has not been scheduled
Quarterly EBITDA
$651.38M$86.53M-11.73%
Summary
- Current Value
- As of today, DVA quarterly EBITDA is $651.38M, down -11.73% on
- Historical Performance
- DVA quarterly EBITDA is up +6.82% year-over-year, up +34.89% over the past 3 years
- All-Time High Comparison
- DVA quarterly EBITDA is currently -11.73% below its historical high of $737.91M set on
- 3-Year Low Comparison
- DVA quarterly EBITDA is +34.89% above its 3-year low of $482.90M reached on an earlier date
- Sector Comparison
- DVA quarterly EBITDA is higher than 95.53% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $651.38M | -11.7% | +6.8% | +34.9% | +8.5% | |
| Annual EBITDA | $2.73B | – | +1.8% | +33.3% | +17.8% | |
| TTM EBITDA | $2.77B | +1.5% | +4.1% | +36.8% | +19.7% | |
| Price | $198.65 | +41.1% | +38.3% | +122.7% | +56.7% | |
| PE Ratio | 19.07 | +29.4% | +34.1% | +12.7% | +0.2% | |
| Quarterly Revenue | $3.42B | -5.6% | +6.0% | +18.9% | +21.1% | |
| Quarterly EPS | $2.87 | -2.3% | +43.1% | +129.6% | +37.5% | |
| $473.55M | -14.1% | +9.3% | +55.4% | +9.0% | ||
| Quarterly Net Income | $275.04M | -10.1% | +18.4% | +61.1% | -5.7% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $737.91M | -11.7% | |
| 3Y | $737.91M | -11.7% | |
| 5Y | $737.91M | -11.7% | |
| All | $737.91M | -11.7% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $609.78M | N/A | +6.8% |
| 3Y | $482.90M | N/A | +34.9% |
| 5Y | $448.50M | +45.2% | |
| All | -$57.00M | +1242.8% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of DVA?
As of today, DVA quarterly EBITDA is $651.38M
What is DVA quarterly EBITDA most recent change?
DVA quarterly EBITDA was down -11.73% on March 31, 2026
What is 1-year change in DVA quarterly EBITDA?
DVA quarterly EBITDA is up +6.82% year-over-year
How far is DVA quarterly EBITDA from its all-time high?
DVA quarterly EBITDA is currently -11.73% below its historical high of $737.91M set on December 31, 2025
How does DVA quarterly EBITDA rank versus sector peers?
DVA quarterly EBITDA is higher than 95.53% of companies in Healthcare sector
When is DVA next earnings release?
The next earnings release for DVA is on
TTM EBITDA
$2.77B$41.60M+1.53%
Summary
- Current Value
- As of today, DVA TTM EBITDA is $2.77B, up +1.53% on
- Historical Performance
- DVA TTM EBITDA is up +4.07% year-over-year, up +36.75% over the past 3 years
- All-Time High Comparison
- DVA TTM EBITDA is currently at its all-time high
- 3-Year Low Comparison
- DVA TTM EBITDA is +37.72% above its 3-year low of $2.01B reached on
- Sector Comparison
- DVA TTM EBITDA is higher than 96.09% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $2.77B | +1.5% | +4.1% | +36.8% | +19.7% | |
| Annual EBITDA | $2.73B | – | +1.8% | +33.3% | +17.8% | |
| Quarterly EBITDA | $651.38M | -11.7% | +6.8% | +34.9% | +8.5% | |
| Price | $198.65 | +41.1% | +38.3% | +122.7% | +56.7% | |
| PE Ratio | 19.07 | +29.4% | +34.1% | +12.7% | +0.2% | |
| TTM Revenue | $13.84B | +1.4% | +6.7% | +18.6% | +20.0% | |
| TTM EPS | $10.42 | +9.0% | +3.1% | +97.6% | +56.5% | |
| $2.05B | +2.0% | +5.4% | +59.5% | +22.7% | ||
| TTM Net Income | $1.10B | +4.1% | -6.8% | +49.6% | +7.7% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $2.77B | at high | |
| 3Y | $2.77B | at high | |
| 5Y | $2.77B | at high | |
| All | $2.77B | at high |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.64B | +4.7% | |
| 3Y | $2.01B | +37.7% | |
| 5Y | $2.01B | +37.7% | |
| All | -$25.40M | >+9999.0% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of DVA?
As of today, DVA TTM EBITDA is $2.77B
What is DVA TTM EBITDA most recent change?
DVA TTM EBITDA was up +1.53% on March 31, 2026
What is 1-year change in DVA TTM EBITDA?
DVA TTM EBITDA is up +4.07% year-over-year
How far is DVA TTM EBITDA from its all-time high?
DVA TTM EBITDA is currently at its all-time high
How does DVA TTM EBITDA rank versus sector peers?
DVA TTM EBITDA is higher than 96.09% of companies in Healthcare sector
When is DVA next earnings release?
The next earnings release for DVA is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- DVA Official Website www.davita.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/927066/000092706626000004/0000927066-26-000004-index.htm
- DVA Profile on Yahoo Finance finance.yahoo.com/quote/DVA
- DVA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/dva